Literature DB >> 27689737

Monocyte type I interferon signature in antiphospholipid syndrome is related to proinflammatory monocyte subsets, hydroxychloroquine and statin use.

Lucas L van den Hoogen1,2, Ruth D E Fritsch-Stork2,3,4, Marjan A Versnel5, Ronald H Wm Derksen2, Joël A G van Roon1,2, Timothy R Dj Radstake1,2.   

Abstract

Entities:  

Keywords:  Antiphospholipid Syndrome; Autoimmune Diseases; Cytokines; Inflammation; Systemic Lupus Erythematosus

Mesh：

Substances：

Year:  2016        PMID： 27689737     DOI： 10.1136/annrheumdis-2016-210485

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  17 in total

Review 1.  New insights into the pathogenic mechanisms and treatment of arterial thrombosis in antiphospholipid syndrome.

Authors:  Yuichiro Fujieda; Olga Amengual
Journal:  Eur J Rheumatol       Date:  2020-11-19

Review 2.  Antiphospholipid syndrome: an update for clinicians and scientists.

Authors:  Andrew P Vreede; Paula L Bockenstedt; Jason S Knight
Journal:  Curr Opin Rheumatol       Date:  2017-09       Impact factor: 5.006

3.  Response to: 'Monocyte type I interferon signature in antiphospholipid syndrome is related to pro-inflammatory monocyte subsets, hydroxychloroquine and statin use' by van den Hoogen et al.

Authors:  Srilakshmi Yalavarthi; Robert C Grenn; Jason S Knight
Journal:  Ann Rheum Dis       Date:  2016-10-21       Impact factor: 19.103

4.  Activated signature of antiphospholipid syndrome neutrophils reveals potential therapeutic target.

Authors:  Jason S Knight; He Meng; Patrick Coit; Srilakshmi Yalavarthi; Gautam Sule; Alex A Gandhi; Robert C Grenn; Levi F Mazza; Ramadan A Ali; Paul Renauer; Jonathan D Wren; Paula L Bockenstedt; Hui Wang; Daniel T Eitzman; Amr H Sawalha
Journal:  JCI Insight       Date:  2017-09-21

5.  A 37-Year-Old Man With Primary Antiphospholipid Syndrome Presenting With Respiratory Distress and Worsening Toe Ischemia.

Authors:  Nayef M Kazzaz; Allecia M Wilson; Ruba Kado; Geoffrey D Barnes; Jason S Knight
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-08       Impact factor: 4.794

Review 6.  An Update on Antiphospholipid Syndrome.

Authors:  Eleni Xourgia; Maria G Tektonidou
Journal:  Curr Rheumatol Rep       Date:  2022-01-05       Impact factor: 4.592

Review 7.  Update on Antiphospholipid Syndrome: Ten Topics in 2017.

Authors:  Ilaria Cavazzana; Laura Andreoli; Maarteen Limper; Franco Franceschini; Angela Tincani
Journal:  Curr Rheumatol Rep       Date:  2018-03-15       Impact factor: 4.592

8.  Antiphospholipid syndrome: state of the art on clinical practice guidelines.

Authors:  Marteen Limper; Carlo Alberto Scirè; Rosaria Talarico; Zahir Amoura; Tadej Avcin; Martina Basile; Gerd Burmester; Linda Carli; Ricard Cervera; Nathalie Costedoat-Chalumeau; Andrea Doria; Thomas Dörner; João Eurico Fonseca; Ilaria Galetti; Eric Hachulla; David Launay; Filipa Lourenco; Carla Macieira; Pierluigi Meroni; Carlo Maurizio Montecucco; Maria Francisca Moraes-Fontes; Luc Mouthon; Cecilia Nalli; Veronique Ramoni; Maria Tektonidou; Jacob M van Laar; Stefano Bombardieri; Matthias Schneider; Vanessa Smith; Ana Vieira; Maurizio Cutolo; Marta Mosca; Angela Tincani
Journal:  RMD Open       Date:  2018-10-18

Review 9.  Antiphospholipid Syndrome Nephropathy: From Pathogenesis to Treatment.

Authors:  Maria G Tektonidou
Journal:  Front Immunol       Date:  2018-05-31       Impact factor: 7.561

10.  Increased B-cell activating factor (BAFF)/B-lymphocyte stimulator (BLyS) in primary antiphospholipid syndrome is associated with higher adjusted global antiphospholipid syndrome scores.

Authors:  Lucas L van den Hoogen; Giovanni Palla; Cornelis P J Bekker; Ruth D E Fritsch-Stork; Timothy R D J Radstake; Joel A G van Roon
Journal:  RMD Open       Date:  2018-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.